Bank Hapoalim BM’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,353
| Closed | -$223K | – | 173 |
|
|
2019
Q1 | $223K | Sell |
4,353
-516
| -11% | -$26.4K | 0.05% | 151 |
|
|
2018
Q4 | $228K | Hold |
4,869
| – | – | 0.07% | 140 |
|
|
2018
Q3 | $272K | Sell |
4,869
-405
| -8% | -$22.6K | 0.07% | 161 |
|
|
2018
Q2 | $266K | Sell |
5,274
-1,440
| -21% | -$72.6K | 0.07% | 162 |
|
|
2018
Q1 | $330K | Sell |
6,714
-294
| -4% | -$14.5K | 0.09% | 149 |
|
|
2017
Q4 | $361 | Sell |
7,008
-1,785
| -20% | -$92 | 0.08% | 147 |
|
|
2017
Q3 | $458K | Sell |
8,793
-2,100
| -19% | -$109K | 0.1% | 145 |
|
|
2017
Q2 | $563K | Sell |
10,893
-5,580
| -34% | -$288K | 0.13% | 111 |
|
|
2017
Q1 | $829K | Buy |
16,473
+6,702
| +69% | +$337K | 0.19% | 98 |
|
|
2016
Q4 | $460K | Buy |
9,771
+5,121
| +110% | +$241K | 0.12% | 121 |
|
|
2016
Q3 | $232K | Hold |
4,650
| – | – | 0.05% | 174 |
|
|
2016
Q2 | $224K | Buy |
+4,650
| New | +$224K | 0.05% | 160 |
|
|
2015
Q3 | – | Sell |
-4,650
| Closed | -$271K | – | 171 |
|
|
2015
Q2 | $271K | Sell |
4,650
-164,160
| -97% | -$9.57M | 0.05% | 158 |
|
|
2015
Q1 | $1.61M | Buy |
168,810
+164,160
| +3,530% | +$1.56M | 0.29% | 61 |
|
|
2014
Q4 | $234K | Hold |
4,650
| – | – | 0.05% | 144 |
|
|
2014
Q3 | $218K | Hold |
4,650
| – | – | 0.05% | 146 |
|
|
2014
Q2 | $209K | Hold |
4,650
| – | – | 0.05% | 145 |
|
|
2014
Q1 | $200K | Buy |
+4,650
| New | +$200K | 0.05% | 138 |
|